Research and Clinical Trials

A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Brief Description  
This is an observational treatment use protocol that will provide IRB oversight and documentation of the clinical experience of patients undergoing treatment for liver carcinoma using TheraSphere (Yttrium-90 glass microspheres).
Who may be Eligible  
Patients with hepatocellular carcinoma of the liver who are not candidates for surgical resections.
Gastrointestinal Cancer
IRB Number  
Principal Investigator  
Iannitti, David

For More Information, Contact  Gale  W, Groseclose
Phone:  (704) 355-4875  Fax:  (704) 355-8147  
Address:Carolinas Medical Center 1000 Blythe Boulevard Medical Education Building, Ste. 103 Charlotte, NC 28203